Flex Pharma Obtains $40,000,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=74bf225a-5a71-4a11-9bcb-c804a4d763ff
Date
9/8/2014
Company Name
Flex Pharma
Mailing Address
800 Boylston St. 24th Floor Boston, MA 02199 USA
Company Description
Most muscle cramps are not caused by dehydration, lactic acid, electrolyte imbalance, or muscle tightness. That is why popular remedies like sports drinks, bananas, magnesium tablets, and stretching are usually ineffective. Flex Pharma is developing products to address muscle cramps and spasms by halting repetitive firing of the motor neurons.
Website
http://www.flex-pharma.com
Transaction Type
Venture Equity
Transaction Amount
$40,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Flex Pharma plans to further advance the science and its clinical candidates addressing neuromuscular disorders with this financing.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor